Pivotal Clinical Trial Costs Estimated at $19 Million

Oct 3, 2018

A new analysis has found it costs an average of $19 million to get new drugs through pivotal clinical trials and onto the market. Researchers at the Institute for Safe Medication Practices and Johns Hopkins University reviewed 59 separate drugs ...

Read More

New cancer vaccine may tackle HER2-positive tumors

Oct 3, 2018

New research shows that a new cancer vaccine may be effective for treating a range of HER2-positive cancers, including the more aggressive HER2-positive breast cancer. A new cancer vaccine showed promise in an early trial. Cancer that is human epidermal growth factor ...

Read More